Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting

Research output: Contribution to journalConference articleResearchpeer-review

Standard

Methotrexate Use and Monitoring in Patients with Psoriasis : A Consensus Report Based on a Danish Expert Meeting. / Raaby, Line; Zachariae, Claus; Østensen, Monika; Heickendorff, Lene; Thielsen, Peter; Grønbæk, Henning; Skov, Lone; Kyvsgaard, Nini; Madsen, Jakob T; Heidenheim, Michael; Funding, Anne T; Strauss, Gitte; Lindberg, Rune; Iversen, Lars.

In: Acta Dermatovenereologica, Vol. 97, No. 4, 2017, p. 426-432.

Research output: Contribution to journalConference articleResearchpeer-review

Harvard

Raaby, L, Zachariae, C, Østensen, M, Heickendorff, L, Thielsen, P, Grønbæk, H, Skov, L, Kyvsgaard, N, Madsen, JT, Heidenheim, M, Funding, AT, Strauss, G, Lindberg, R & Iversen, L 2017, 'Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting', Acta Dermatovenereologica, vol. 97, no. 4, pp. 426-432. https://doi.org/10.2340/00015555-2599

APA

Raaby, L., Zachariae, C., Østensen, M., Heickendorff, L., Thielsen, P., Grønbæk, H., ... Iversen, L. (2017). Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. Acta Dermatovenereologica, 97(4), 426-432. https://doi.org/10.2340/00015555-2599

Vancouver

Raaby L, Zachariae C, Østensen M, Heickendorff L, Thielsen P, Grønbæk H et al. Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. Acta Dermatovenereologica. 2017;97(4):426-432. https://doi.org/10.2340/00015555-2599

Author

Raaby, Line ; Zachariae, Claus ; Østensen, Monika ; Heickendorff, Lene ; Thielsen, Peter ; Grønbæk, Henning ; Skov, Lone ; Kyvsgaard, Nini ; Madsen, Jakob T ; Heidenheim, Michael ; Funding, Anne T ; Strauss, Gitte ; Lindberg, Rune ; Iversen, Lars. / Methotrexate Use and Monitoring in Patients with Psoriasis : A Consensus Report Based on a Danish Expert Meeting. In: Acta Dermatovenereologica. 2017 ; Vol. 97, No. 4. pp. 426-432.

Bibtex

@inproceedings{fc588b61b7c84d248c93eb7666086e9a,
title = "Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting",
abstract = "Methotrexate (MTX) has been used in the treatment of psoriasis and other dermatological diseases for more than 50 years. However, there is limited evidence regarding its effect, dose and monitoring, and a lack of consensus regarding how the drug should be used in daily practice. Although the use of MTX is governed by guidelines, such as the European S3-Guidelines and the National Institute for Health and Care Excellence (NICE) guideline, it is important to discuss and adjust these guidelines to national standards. An expert meeting was held in Denmark at the end of 2014, in order to reach consensus regarding the use of MTX in dermatological practice in Denmark. Participants included dermatologists, hepatologists, paediatricians, clinical biochemists and a rheumatologist. Topics discussed were: liver disease monitoring, teratogenic effects of MTX, risk of cancer, and use of MTX in children. We report here the conclusions of this expert meeting regarding use of MTX in dermatological practice.",
author = "Line Raaby and Claus Zachariae and Monika {\O}stensen and Lene Heickendorff and Peter Thielsen and Henning Gr{\o}nb{\ae}k and Lone Skov and Nini Kyvsgaard and Madsen, {Jakob T} and Michael Heidenheim and Funding, {Anne T} and Gitte Strauss and Rune Lindberg and Lars Iversen",
year = "2017",
doi = "10.2340/00015555-2599",
language = "English",
volume = "97",
pages = "426--432",
journal = "Acta Dermatovenereologica",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato - Venereologica",
number = "4",

}

RIS

TY - GEN

T1 - Methotrexate Use and Monitoring in Patients with Psoriasis

T2 - A Consensus Report Based on a Danish Expert Meeting

AU - Raaby, Line

AU - Zachariae, Claus

AU - Østensen, Monika

AU - Heickendorff, Lene

AU - Thielsen, Peter

AU - Grønbæk, Henning

AU - Skov, Lone

AU - Kyvsgaard, Nini

AU - Madsen, Jakob T

AU - Heidenheim, Michael

AU - Funding, Anne T

AU - Strauss, Gitte

AU - Lindberg, Rune

AU - Iversen, Lars

PY - 2017

Y1 - 2017

N2 - Methotrexate (MTX) has been used in the treatment of psoriasis and other dermatological diseases for more than 50 years. However, there is limited evidence regarding its effect, dose and monitoring, and a lack of consensus regarding how the drug should be used in daily practice. Although the use of MTX is governed by guidelines, such as the European S3-Guidelines and the National Institute for Health and Care Excellence (NICE) guideline, it is important to discuss and adjust these guidelines to national standards. An expert meeting was held in Denmark at the end of 2014, in order to reach consensus regarding the use of MTX in dermatological practice in Denmark. Participants included dermatologists, hepatologists, paediatricians, clinical biochemists and a rheumatologist. Topics discussed were: liver disease monitoring, teratogenic effects of MTX, risk of cancer, and use of MTX in children. We report here the conclusions of this expert meeting regarding use of MTX in dermatological practice.

AB - Methotrexate (MTX) has been used in the treatment of psoriasis and other dermatological diseases for more than 50 years. However, there is limited evidence regarding its effect, dose and monitoring, and a lack of consensus regarding how the drug should be used in daily practice. Although the use of MTX is governed by guidelines, such as the European S3-Guidelines and the National Institute for Health and Care Excellence (NICE) guideline, it is important to discuss and adjust these guidelines to national standards. An expert meeting was held in Denmark at the end of 2014, in order to reach consensus regarding the use of MTX in dermatological practice in Denmark. Participants included dermatologists, hepatologists, paediatricians, clinical biochemists and a rheumatologist. Topics discussed were: liver disease monitoring, teratogenic effects of MTX, risk of cancer, and use of MTX in children. We report here the conclusions of this expert meeting regarding use of MTX in dermatological practice.

U2 - 10.2340/00015555-2599

DO - 10.2340/00015555-2599

M3 - Conference article

C2 - 27958611

VL - 97

SP - 426

EP - 432

JO - Acta Dermatovenereologica

JF - Acta Dermatovenereologica

SN - 0001-5555

IS - 4

ER -

ID: 173675142